Bluebird bio Inc and Bristol-Myers Squibb Co on Monday reported encouraging initial data from an ongoing early-stage study testing their experimental therapy for multiple myeloma in patients who did not respond to prior treatments.
from Reuters: Health https://ift.tt/2PsFPdU
via IFTTT
Home
Health
Reuters: Health
Bluebird bio, Bristol-Myers' multiple myeloma therapy shows promise in early study
0 comments: